| Literature DB >> 12867115 |
J Sanders1, M Evans, L D K E Premawardhana, H Depraetere, J Jeffreys, T Richards, J Furmaniak, B Rees Smith.
Abstract
A monoclonal autoantibody (MAb) with powerful thyroid stimulating activity has been produced from lymphocytes from a patient with Graves' disease. The autoantibody and its Fab fragment bind to the thyroid stimulating hormone (TSH) receptor (TSHR) with high affinity, inhibit labelled TSH binding to the receptor and stimulate cyclic AMP production in Chinese hamster ovary cells transfected with TSHR. TSHR autoantibodies with TSH agonist or antagonist activities from patients' serum samples are effective inhibitors of labelled monoclonal autoantibody binding to TSHR. Thus, the human monoclonal autoantibody has all the characteristics of serum TSHR autoantibodies. Its availability has important implications for new studies on the pathogenesis of Graves' disease.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12867115 DOI： 10.1016/s0140-6736(03)13866-4
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321